• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

VisiQuate Acquires AI-Powered RCM Automation Platform Rotera

by Syed Hamza Sohail 03/26/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

–  VisiQuate, a leader in AI-powered revenue cycle management (RCM), has acquired Rotera, strengthening AI-driven automation in healthcare.

– This strategic acquisition enhances VisiQuate’s Machina Automation Studio, delivering next-generation agentic AI to help healthcare organizations optimize financial operations and reduce manual intervention.

VisiQuate Expands AI-Driven Revenue Cycle Automation with Rotera Acquisition

VisiQuate, a leader in revenue cycle automation, has acquired Rotera to enhance AI-driven revenue cycle management. This strategic move strengthens VisiQuate’s ability to develop intelligent, self-learning workflows that eliminate inefficiencies, optimize cash flow, and reduce administrative burdens at scale.

“With Rotera’s deep automation expertise and next-generation agentic AI technology, we are accelerating the evolution of revenue cycle automation,” said Brian Robertson, Founder & CEO of VisiQuate. “This acquisition reinforces our commitment to delivering the most advanced automation solutions, allowing healthcare organizations to focus their resources where they matter most—on patient care.”

A key aspect of this integration is enhancing Ana, VisiQuate’s intelligence suite, by embedding Rotera’s automation capabilities. This advancement enables Ana to:

·       Drive efficiency and streamline workflows

·       Improve employee productivity through automation

·       Enhance real-time data interaction and automate high-friction processes

·       Proactively manage revenue cycle tasks with minimal human intervention

By combining VisiQuate’s industry-leading analytics with Rotera’s AI frameworks, Ana becomes a more powerful tool, ensuring greater intelligence, productivity, and decision-making at every stage of the revenue cycle.

VisiQuate delivers AI-driven automation, advanced analytics, and intelligent workflows designed to reduce inefficiencies, accelerate cash flow, and recover more revenue with less effort. Unlike traditional revenue cycle management solutions, VisiQuate provides actionable insights that help healthcare organizations:

·       Predict and prevent revenue cycle bottlenecks

·       Streamline claim and payment processes

·       Maximize revenue by reducing denials and adapting to shifting payer behaviors

With the combined strength of VisiQuate and Rotera, the company is positioned for rapid innovation and growth, offering scalable AI-driven solutions that enhance financial health and operational efficiency across healthcare organizations.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |